Veerayyagari Annapurna
Obstetrics & Gynecology · Great Bend, KSNPI 1073783437
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 42.6% of the total. Reporting peaked in 2021 at $558 and has fallen 83.2% since, to $94 in 2025.
Across 88 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$664
- Smith+Nephew$141
- Medtronic$103
- Sumitomo Pharma America, Inc.$78
- Bayer$74
- Aspira Women's Health Inc$70
- plus $429 from 17 others
What the payments were for
- Food & beverage$1,559100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $664 |
| Smith+Nephew | 5 | $141 |
| Medtronic | 2 | $103 |
| Sumitomo Pharma America, Inc. | 4 | $78 |
| Bayer | 5 | $74 |
| Aspira Women's Health Inc | 1 | $70 |
| Hologic Sales And Service, LLC | 4 | $63 |
| Therapeuticsmd, Inc. | 4 | $52 |
| Evofem Biosciences, Inc. | 3 | $46 |
| Coopersurgical, Inc. | 2 | $41 |
| Myovant Sciences Inc. | 2 | $33 |
| Novo Nordisk | 2 | $27 |
| Amgen | 2 | $26 |
| Lilly USA, LLC | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Biogen | 1 | $14 |
| GSK | 1 | $13 |
| Pfizer | 1 | $13 |
| Exeltis, USA Inc. | 1 | $12 |
| Urovant Sciences Inc | 1 | $12 |
| Duchesnay USA Incorporated | 1 | $11 |
| Covidien LP | 1 | $11 |
How this compares
$1,559 in reported general payments places this provider in the 60th percentile of 302 obstetrics & gynecology providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 15 | $171 |
| Medroxyprogesterone Acetate | 20 | $94 |
| Levothyroxine Sodium | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Great Bend
- Jodi HenriksonGreat Bend$8K
- Kimberly SwanOverland Park$123K
- Michael FenechPittsburg$65K
- Michael MageeShawnee Mission$28K
- Austin FindleyKansas City$18K
- Madhuri ReddyKansas City$13K
- Deshala CastilleEmporia$11K
- Christine SandersHutchinson$11K
- Zachary KuhlmannWichita$11K
- Angela ShawPittsburg$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.